| doxercalciferol / Generic mfg. |
2007-001043-22: A Multicenter, Open-Label Study of Hectorol (doxercalciferol capsules) for the Treatment of Secondary Hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease (CKD) Patients |
|
|
| Completed | 3 | 200 | Europe | doxercalciferol capsules, Film-coated tablet | Genzyme Europe BV | Secondary hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease | | | | |
NCT02282813: Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 |
|
|
| Completed | 3 | 298 | US | CTAP101 Capsules, Calcifediol, Calcitriol, calcifediol, Doxercalciferol, Paricalcitol | OPKO Health, Inc. | Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency | 05/15 | 05/15 | | |
ChiCTR2100052077: Clinical study on the treatment of secondary hyperparathyroidism in patients with maintenance hemodialysis by Doxercalciferol injection |
|
|
| Not yet recruiting | 3 | 40 | | Doxercalciferol injection for treatment | Renji Hospital, Shanghai Tiaotong University School of Medicine; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Self-funded | Secondary hyperparathyroidism in hemodialysis patients | | | | |
NCT02859896: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis |
|
|
| Active, not recruiting | 3 | 84 | US, RoW | Doxercalciferol (GZ427397), Hectorol, Calcitriol, Rocaltrol | Sanofi | Secondary Hyperparathyroidism-Chronic Kidney Disease | 11/25 | 11/25 | | |
